NexLife vs Henry Meds (2026): Structure, Verified Figures, and Open Questions

NexLife vs Henry Meds: what’s verified, what’s structural, what’s pending

Updated: 2026-08-20 Medical review: pending

Disclosure — read before the review

Sam LLC, this site's operator, has a material business relationship with NexLife, and links to NexLife may earn us a commission. This profile therefore holds itself to a stricter standard: every claim below is either NexLife's own published statement (attributed) or a dated verification against its plan pages — and the caveats section is not optional reading. Full disclosure · methodology.

The short version

This is the cleanest structural matchup in the directory: two flat-monthly pitches, no insurance, cash pay. The entire comparison reduces to whose flat number is lower once membership, shipping, and dose changes are counted — which is precisely the 18-field ledger. NexLife’s column is verified at $139–169 tirzepatide all-in; Henry’s column is queued.

How NexLife works

NexLife sells a flat-rate cash bundle: one monthly price that includes the medication, supplies, clinician access, and support, with the rate locked for as long as you stay on the plan and no membership, consult, or dose-change fees. Verified 2026-08-20: tirzepatide $169/mo month-to-month down to $139/mo on a 12-month term ($1,668/yr all-in); semaglutide $139 down to $119 ($1,428/yr). Caveats we apply to NexLife as to everyone: its ODT formats carry no published outcome trials, and compounded products occupy a contested post-shortage legal lane. NexLife has a disclosed material connection to this site.

How Henry Meds works

Henry Meds built one of the loudest advertising presences in the category on a simple pitch: flat monthly pricing for compounded GLP-1 therapy, no insurance involved, fast starts. That makes it one of the most direct structural comparators to a flat-rate program — the whole question collapses to whose flat number is lower once membership, shipping, and dose changes are counted, which is exactly what our 18-field ledger is built to answer. The post-shortage enforcement landscape matters more for compounded-first brands than anyone else, so our verification will document formulation, pharmacy type (503A vs 503B), and the stated legal pathway alongside price.

Verified vs pending

One side of this table is verified and dated; the other is queued. We will not fill the blank side with advertised prices dressed up as findings.

Full files

NexLife provider file · Henry Meds provider file · the pricing ledger · 2-minute match quiz. Have a current receipt from either program? Corrections moves it up the queue.